Latest News

Back to resources

Displaying 1 - 8 of 10

Clinical & Medical
Predictions for the role of CRAs in an era of decentralisation
The clinical research landscape is undergoing a huge transformation, and with it brings a sh...

By Toby Rodd September 29th, 2024
Clinical & Medical
Building KOL relationships in medical affairs
As an MSL, you know that building solid relationships with Key Opinion Leaders (KOLs) is cru...

By SEC Newsroom September 15th, 2024
Clinical & Medical
How medical affairs professionals can effectively engage KOLs
Key opinion leaders (KOLs) are crucial in both the development of medical therapies and clin...

By SEC Newsroom May 23rd, 2024
Clinical & Medical, DE&I
The push for greater diversity in clinical trials and what it means for the future of patient recruitment
Recruitment problems are the one of the biggest cause of clinical trial delays, with ar...

By SEC Newsroom February 12th, 2024
Clinical & Medical
A guide to hiring future-ready MSLs
Medical science liaisons (MSLs) are the behind-the-scenes heroes in the life sciences space....

By SEC Newsroom August 8th, 2023
Clinical & Medical, DE&I
How the decentralised trial model could be a catalyst for global health equity
The life sciences industry has seen a surge in the adoption of decentralised clinical trial...

By SEC Newsroom April 3rd, 2023
Clinical & Medical
Why remote work lends itself well to clinical sector roles
In 2011 Pfizer conducted a world-first fully “virtual” trial. In the space of a...

By SEC Newsroom February 20th, 2023
Clinical & Medical
The move towards decentralised trials and its impact on clinical sector roles
Difficulty in reaching target patient populations. High drop-out rates from trial participan...

By SEC Newsroom October 26th, 2022